SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001085146-22-000843
Filing Date
2022-02-11
Accepted
2022-02-11 13:00:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 CHI ADVISORS LLC frln_21122.htm SC 13G 26309
  Complete submission text file 0001085146-22-000843.txt   28034
Mailing Address 599 LEXINGTON AVENUE 20TH FLOOR NEW YORK NY 10022
Business Address 599 LEXINGTON AVENUE 20TH FLOOR NEW YORK NY 10022 2122014829
CHI Advisors LLC (Filed by) CIK: 0001791468 (see all company filings)

IRS No.: 141874283 | State of Incorp.: DE | Fiscal Year End: 1230
Type: SC 13G

Mailing Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2FX
Business Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2FX 44 (0)1438 906870
Freeline Therapeutics Holdings plc (Subject) CIK: 0001810031 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91620 | Film No.: 22618829
SIC: 2836 Biological Products, (No Diagnostic Substances)